COMPANY INFO
Ascertain is a healthcare AI company founded in 2022 and based in New York City. The company was co-founded by John Beadle and Mark Michalski, M.D., who is also the CEO. Ascertain operates as an AI-based business management tool designed to automate routine administrative tasks for healthcare providers, enabling clinical teams to focus more on patient care. It has raised $17.4 million in funding and currently has around 28 employees. The company is part of the healthcare technology industry and is supported by investors including Deerfield and Northwell Health. Its official website is ascertain.com.
Ascertain is a healthcare AI company founded in 2022 and headquartered in New York City. Specializing in AI-based business management tools, Ascertain automates routine administrative tasks for healthcare providers, empowering clinical teams to dedicate more focus to patient care. With a core team of around 26 employees, the company operates at the intersection of healthcare technology and artificial intelligence, aiming to enhance operational efficiencies in the medical sector.
Ascertain’s funding history showcases its rapid growth and appeal to venture investors in the healthcare AI space. The company has raised a total of $17.4 million across 2 funding rounds. Its funding strategy reflects a clear trajectory—from early-stage, product-focused investment to a substantial Series A round designed to accelerate growth, fuel product development, and drive market expansion. Key milestones include its initial launch supported by an unattributed round and a significant Series A round in 2025, led by renowned healthcare investment firms. Such backing underscores Ascertain’s strategic approach to building strong partnerships and securing industry-aligned investors.
The Series A round, led by Deerfield and Northwell, raised $10 million. This funding is being used for growth initiatives, product development, and market expansion as Ascertain further integrates its AI solutions into healthcare workflows.
This early, unattributed funding round, totaling $7.38 million, likely supported Ascertain’s initial launch, product development efforts, and foundational company operations.
Deerfield Management is a renowned healthcare-focused investment firm based in New York. As a lead investor in Ascertain's Series A round, Deerfield provides not only capital but also strategic insight and industry relationships within life sciences, supporting Ascertain’s scale-up and deeper market penetration.
Northwell Health, New York's largest healthcare provider, also played a leading role in Ascertain’s Series A funding. As a key institutional investor and strategic partner, Northwell brings clinical expertise and access to a vast health network, enabling Ascertain to validate and deploy its AI tools in real-world healthcare environments.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive funding information for any company. Whether you're researching Ascertain funding rounds or exploring investment data for other companies, Websets provides detailed insights into funding history, investors, and financial milestones.
With Websets, you can access detailed funding profiles, investor information, and financial data through intuitive natural language queries. Sign up now to enhance your funding research capabilities.